New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
10:14 EDTTKMRTekmira extends its recent rally, levels to watch
Shares are up over 19.7% to $24.75 at time of writing. At that price, next resistance is at the high of the session at $26.05. Support is at $24.01. Volume is heavy, running at nearly nine times daily average.
News For TKMR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
11:32 EDTTKMRTekmira to host special shareholder meeting
Subscribe for More Information
05:27 EDTTKMRTekmira announces update to proxy circular on merger with OnCore
Tekmira Pharmaceuticals announced an update to persons who will serve as members of the board of the company upon completion of the company's proposed business combination with OnCore Biopharma, as described in the company's proxy circular regarding the transaction, dated February 4. The board of the combined company upon completion of the merger will consist of Vivek Ramaswamy, who will serve as chairman of the board, Mark Murray, Ph.D., Richard Henriques, Jr., Keith Manchester, Frank Karbe, William T. Symonds, Pharm. D., and Herbert Conrad. Daniel Kisner, M.D., will not serve as a director or vice chairman of the board for the combined company.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use